{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:38:56Z","timestamp":1775756336649,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.amjcard.2012.12.045","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T11:15:49Z","timestamp":1358507749000},"page":"1159-1164","source":"Crossref","is-referenced-by-count":103,"title":["Renal Impairment in a \u201cReal-Life\u201d Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)"],"prefix":"10.1016","volume":"111","author":[{"given":"Vanessa","family":"Rold\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herm\u00f3genes","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Manzano-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.12.045_bib1","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2010.12.033","article-title":"Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients","volume":"57","author":"Rold\u00e1n","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCEP.111.967000","article-title":"Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events and mortality in anticoagulated patients with atrial fibrillation","volume":"5","author":"Gallego","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib3","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.12.045_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2012.12.045_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2012.12.045_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2012.12.045_bib7","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines form chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2012.12.045_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.045_bib9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1538-7836.2011.04347.x","article-title":"Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs","volume":"9","author":"Kooiman","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2012.12.045_bib10","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk In Communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.045_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2011.04.022","article-title":"Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: a subgroup analysis from the AURICULA registry in Sweden","volume":"128","author":"J\u00f6nsson","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2012.12.045_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2010.10.074","article-title":"Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation","volume":"107","author":"Nakagawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000329118","article-title":"Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study","volume":"34","author":"Fujii","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2010.12.013","article-title":"Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk","volume":"57","author":"Marinigh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib15","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.clinthera.2009.07.015","article-title":"Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis","volume":"31","author":"Abdelhafiz","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2012.12.045_bib16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2004.11.015","article-title":"Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"Dimarco","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.12.045_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1160\/TH11-08-0524","article-title":"Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting","volume":"107","author":"Manzano-Fern\u00e1ndez","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2012.12.045_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2012.12.045_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2012.12.045_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.12.045_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.045_bib23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/europace\/euq387","article-title":"Warfarin in haemodialysis patients with atrial fibrillation: what benefit?","volume":"12","author":"Yang","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2012.12.045_bib24","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/eurheartj\/ehr344","article-title":"Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope","volume":"32","author":"Hohnloser","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.12.045_bib25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1160\/TH11-05-0358","article-title":"Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation: a consensus document of the Italian Federation of Thrombosis Centers (FCSA)","volume":"106","author":"Pengo","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2012.12.045_bib26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2165\/11635730-000000000-00000","article-title":"New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function","volume":"72","author":"Poulsen","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.amjcard.2012.12.045_bib27","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1681\/ASN.2008070802","article-title":"Kidney function influences warfarin responsiveness and hemorrhagic complications","volume":"20","author":"Limdi","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2012.12.045_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH08-11-0730","article-title":"Bleeding with anticoagulation therapy\u2014who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2012.12.045_bib30","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ndt\/gfr500","article-title":"Acute and chronic nephropathy induced by fluindione must be addressed","volume":"27","author":"Cam","year":"2012","journal-title":"Nephrol Dial Transplant"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912026483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912026483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T09:40:10Z","timestamp":1562578810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912026483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002914912026483"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.045","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}